研究人員通過大規模計算機仿真研究的結果，發現一個分子結構的微小改變，可以說明肺炎鏈球菌產生耐藥性的原因。這種細菌每年導致大量兒童肺炎并奪去3.5百萬人的生命，主要是在發展中國家。

迄今為止，還沒有進行過實驗研究分子水平的改變是如何導致這種藥物耐藥性的。這些新發現的結果對設計研制新的能夠有效對抗這種耐藥菌株的藥物十分重要。這些結果是由Peter教授和來自瑪麗女王倫敦大學研究院、倫敦大學的研究人員，通過使用計算機模型技術二發現的。他們的研究結果發表在2005年8月15日的《皇家學會的哲學學報》的專刊之上。

研究人員使用從來自其它細菌的實驗資料構建了這些位點的計算機模型，在這些位點藥物分子與細菌的蛋白質分子相互作用。然后他們進行模擬并觀察當藥物分子進入正常和耐藥肺炎鏈球菌的這些位點后，到底發生了什么。這種模擬仿真與可視化探索了大量的平行密碼，在英國國家超級計算機部門運行。

Coveny教授與他的同事發現了正常與耐藥菌株之間很小但是很敏感的結構差異，而正是這些差異導致了藥物耐藥性的產生。在正常菌株，藥物分子能夠與該位點緊密結合，但是在耐藥菌株，藥物進入此位點然后慢慢的漂移。研究人員相信這個發現指出了研制新藥戰勝這種疾病的途徑。
 
New Insights Into Antibiotic Resistance
 
Researchers working with large-scale computer simulations have discovered a tiny change in molecular structure that may account for drug resistance in Streptomices pneumoniae, the organism that causes childhood pneumonia and claims 3.5 million lives a year, mainly in developing countries.

Until now, no experiments have been conducted to find how changes at the molecular level are causing this resistance. The new finding may be very useful in designing new drugs that are effective against the drug-resistant strain. It was discovered by Prof. Peter Coveny and co-workers from the University College London (UK) and Queen Mary, University of London (UK), using computer modeling techniques. The results of their work were published in the August 15, 2005, issue of a special theme issue of Philosophical Transactions of the Royal Society.

The researchers took experimental data gathered from other organisms to build computer models of the sites where drug molecules interact with an organism’s protein molecules. Then they ran simulations and visualized what happens when a drug molecule approaches each site for both normal and drug-resistant strains of S pneumoniae. The simulations and visualizations exploited highly scalable parallel code, running on the UK’s national supercomputing facilities.

Prof. Coveny and his colleagues could see that a very small but subtle difference in structure beween the normal and drug-resistant strains was to blame for the drug resistance. In the normal strain, a drug molecule binds tightly to the site, but in the drug-resistant strain, it approaches and then drifts slowly away. The researchers believe this finding may point the way to new drugs that can combat disease.